Penumbra Inc - Company Profile
Powered by 
All the sales intelligence you need on Penumbra Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Penumbra Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Penumbra Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Penumbra Inc (Penumbra) is a medical device company that designs, develops, and manufactures products for neuro and vascular markets. Its products find use in procedures such as thrombectomy and embolization for treating conditions such as acute ischemic stroke, brain aneurysm, acute limb ischemia, deep vein thrombosis, neuro arteriovenous malformation, and body aneurysm, among others. Its major products include neurovascular access systems, revascularization devices, embolization coiling systems and microcatheters. The company sells its products to specialist physicians, hospitals and clinics through a direct sales organization. It also distributes its products through distributors globally. It has operations in the US, Brazil, Germany, Australia, Canada, Singapore, France and the UK. Penumbra is headquartered in Alameda, California, the US.
Headquarters
United States of America
Address
1310 Harbor Bay Parkway, Alameda, California, 94502
Website
www.penumbrainc.com
Telephone
1 302 5310855
No of Employees
4,700
Industry
Medical Equipment
Ticker Symbol & Exchange
PEN (NYSE)
Revenue (2024)
$1.4B
17.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
1168.1%
(2024 vs 2023)
Market Cap*
$12.4B
Net Profit Margin (2024)
XYZ
982.1%
(2024 vs 2023)
* As of and is in US$
Penumbra Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Neuro: | Ruby |
| Neuro Thrombectomy | JET |
| Neuro Embolization | Indigo System |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Others | In June, the company won the CE Mark in Europe for THUNDERBOLT. |
| 2026 | Contracts/Agreements | In January, the company signed an agreement to be acquired by Boston Scientific Corporation. |
| 2025 | Plans/Strategy | In September, the company announced its plans to open its new manufacturing facility in Costa Rica. |
Competitor Comparison
| Key Parameters | Penumbra Inc | Medtronic Plc | Stryker Corp | Boston Scientific Corp | Inari Medical Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Ireland | United States of America | United States of America | United States of America |
| City | Alameda | Dublin | Portage | Marlborough | Irvine |
| State/Province | California | - | Michigan | Massachusetts | California |
| No. of Employees | 4,700 | 95,000 | 56,000 | 59,000 | 1,300 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Adam Elsesser | Chairman; Chief Executive Officer | Executive Board | 2004 | 64 |
| Maggie Yuen | Chief Financial Officer | Senior Management | 2019 | 54 |
| Lambert Shiu | Chief Accounting Officer | Senior Management | 2019 | 46 |
| Pankaj Tiwari | Chief Information Officer; Executive Vice President | Senior Management | 2016 | - |
| James F. Benenati, M.D. | Chief Medical Officer | Senior Management | 2020 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer